Agents and Actions

, Volume 6, Issue 5, pp 651–656 | Cite as

Influence of adjuvant arthritis on connective-tissue metabolism

  • B. Exer
  • P. Krupp
  • R. Menassé
  • L. Riesterer
Immunosuppression and Inflammation Research Reports


In rats with adjuvant arthritis, an analysis was made of the metabolism of sulfated proteoglycans, with particular attention to the dorsal skin and the extremities. Alterations were demonstrated in all the tissues examined. In the uninflamed dorsal skin, the uptake of exogenous sulfate was diminished. By contrast, in both hind limbs, at the injected and the non-injected site, the turnover of sulfated mucopolysaccharides was increased, above all in ligament and cartilage; the calcium content of the bone tissue of both hind legs was, however, not affected by the disease.


Calcium Sulfated Arthritis Bone Tissue Hind Limb 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    C. M. Pearson, Proc. Soc. exp. Biol. Med.91, 95 (1956).PubMedGoogle Scholar
  2. [2]
    C. M. Pearson, B. H. Waksman andJ. T. Sharp, J. exp. Med.113, 1485 (1961).Google Scholar
  3. [3]
    C. M. Pearson andT. D. Wood, Arthritis Rheum.2, 440 (1959).Google Scholar
  4. [4]
    S. J. Piliero, M. L. Graeme, E. B. Sigg, G. Chinea andC. Colombo, Life Sci.5, 1057 (1966).PubMedGoogle Scholar
  5. [5]
    E. M. Glenn, J. Grey andW. Kooyers, Am. J. vet. Res.26, 1195 (1965).Google Scholar
  6. [6]
    B. H. Waksman andCh. Wennersten, Int. Arch. Allergy23, 129 (1963).PubMedGoogle Scholar
  7. [7]
    D. J. Whitehouse, M. W. Whitehouse andC. M. Pearson, Nature224, 1392 (1969).Google Scholar
  8. [8]
    Z. Trnavská, J. Grimova andC. Trnavsky, Ann. rheum. Dis.31, 334 (1972).PubMedGoogle Scholar
  9. [9]
    C. Trnavsky, Z. Trnavská andJ. Grimova, Rheumatology3, 204 (1973).Google Scholar
  10. [10]
    J. Gietka, Abstract 729, Internat. Congress of Pharmacology, Prag 1969.Google Scholar
  11. [11]
    S. Gurin andD. B. Hood, J. Biol. Chem.131, 211 (1939).Google Scholar
  12. [12]
    K. Fehr,Pathogenese der progredient chronischen Polyarthritis, (Verlag Hans Huber, Bern 1972).Google Scholar
  13. [13]
    M. E. Rosenthale andC. L. Nagra, Proc. Soc. exp. Biol. Med.125, 149 (1967).PubMedGoogle Scholar
  14. [14]
    L. L. Layton, Proc. Soc. exp. Biol. Med.76, 596 (1951).PubMedGoogle Scholar
  15. [15]
    S. Schiller andA. Dorfmann, Endocrinology60, 376 (1957).PubMedGoogle Scholar
  16. [16]
    E. Buddecke, W. Krötz andE. Lanka, Hoppe-Seyler's J. physiol. Chem.331, 1961 (1963).Google Scholar
  17. [17]
    P. D. Mier, Curr. Probl. Derm., vol. 4, (Karger Verlag, Basel 1972), p. 48.Google Scholar
  18. [18]
    W. H. Hauss, G. Junge-Hülsing andU. Gerlach,Die unspezifische Mesenchymreaktion (Georg Thieme Verlag, Stuttgart 1968).Google Scholar

Copyright information

© Birkhäuser-Verlag 1976

Authors and Affiliations

  • B. Exer
    • 1
  • P. Krupp
    • 1
  • R. Menassé
    • 1
  • L. Riesterer
    • 1
  1. 1.Research Department, Pharmaceuticals DivisionCIBA-GEIGY LimitedBasleSwitzerland

Personalised recommendations